Literature DB >> 11864613

A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

Xue Wang1, Marie C DeFrances, Yu Dai, Peter Pediaditakis, Carla Johnson, Aaron Bell, George K Michalopoulos, Reza Zarnegar.   

Abstract

Death receptors such as Fas are present in a variety of organs including liver and play an important role in homeostasis. What prevents these harmful receptors from forming homooligomers, clustering, and initiating the apoptotic pathway is not known. Here, we report the discovery of a cell survival mechanism by which Met, a growth factor receptor tyrosine kinase, directly binds to and sequesters the death receptor Fas in hepatocytes. This interaction prevents Fas self-aggregation and Fas ligand binding, thus inhibiting Fas activation and apoptosis. Our results describe a direct link between growth factor tyrosine kinase receptors and death receptors to establish a novel paradigm in growth regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864613     DOI: 10.1016/s1097-2765(02)00439-2

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  77 in total

1.  Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage.

Authors:  David Tulasne; Julien Deheuninck; Filipe Calheiros Lourenco; Fabienne Lamballe; Zongling Ji; Catherine Leroy; Emilie Puchois; Anice Moumen; Flavio Maina; Patrick Mehlen; Véronique Fafeur
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 2.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

3.  Novel proapoptotic effect of hepatocyte growth factor: synergy with palmitate to cause pancreatic {beta}-cell apoptosis.

Authors:  José A González-Pertusa; John Dubé; Shelley R Valle; Taylor C Rosa; Karen K Takane; José M Mellado-Gil; Germán Perdomo; Rupangi C Vasavada; Adolfo García-Ocaña
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

4.  The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

Authors:  Luis J Herrera; Talal El-Hefnawy; Pierre E Queiroz de Oliveira; Siva Raja; Sydney Finkelstein; William Gooding; James D Luketich; Tony E Godfrey; Steven J Hughes
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

5.  Fas ligand enhances malignant behavior of tumor cells through interaction with Met, hepatocyte growth factor receptor, in lipid rafts.

Authors:  Huan-Ching Lin; Po-Yin Lai; Yu-ping Lin; Jyun-Yuan Huang; Bei-Chang Yang
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

Review 6.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

7.  Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.

Authors:  Ying Zhang; Kaitlyn E Farenholtz; Yanzhi Yang; Fadila Guessous; Charles G Dipierro; Valerie S Calvert; Jianghong Deng; David Schiff; Wenjun Xin; Jae K Lee; Benjamin Purow; James Christensen; Emanuel Petricoin; Roger Abounader
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

Review 8.  Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

Authors:  Jacquelyn J Maher; Pablo Leon; James C Ryan
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

9.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair.

Authors:  Chang-Goo Huh; Valentina M Factor; Aránzazu Sánchez; Koichi Uchida; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

Review 10.  Rejuvenating Bi(d)ology.

Authors:  S S Zinkel; X M Yin; A Gross
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.